HIV Vaccines
SKU
MRR-4312A385A507
Region
Global
Publication Date
March 2024
Delivery
Immediate
2023
USD 677.83 million
2030
USD 7,011.84 million
2024
USD 943.11 million
CAGR
39.62%

HIV Vaccines Market by Antibodies (Dicloxacillin, Fusidic Acid Ointment, Gentamicin Ointment), Type (Acute Paronychia, Candidal Paronychia, Chronic Paronychia), Category - Global Forecast 2024-2030

[182 Pages Report] The HIV Vaccines Market size was estimated at USD 677.83 million in 2023 and expected to reach USD 943.11 million in 2024, at a CAGR 39.62% to reach USD 7,011.84 million by 2030.

HIV Vaccines Market
To learn more about this report, request a free PDF copy
HIV Vaccines Market - Global Forecast 2024-2030
To learn more about this report, request a free PDF copy
FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the HIV Vaccines Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the HIV Vaccines Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the HIV Vaccines Market, highlighting leading vendors and their innovative profiles. These include AlphaVax, Inc., Antigen Express, Inc., Argos Therapeutics, Inc., Bionor Pharmaceuticals, Celldex Therapeutics, Inc., Crucell N.V., GeneCure LLC, Genetic Immunity, Inc., GenVec, Inc., GeoVax Labs, Inc., GlaxoSmithKline plc, Immune Response BioPharma, Inc., Inovio Pharmaceuticals, Inc., Novartis AG, Oncolys Biopharma, Profectus Biosciences, Sanofi SA, and TVAX Biomedical.

Market Segmentation & Coverage

This research report categorizes the HIV Vaccines Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Antibodies
    • Dicloxacillin
    • Fusidic Acid Ointment
    • Gentamicin Ointment
    • Mupirocin Ointment
  • Type
    • Acute Paronychia
    • Candidal Paronychia
    • Chronic Paronychia
    • Pyogenic Paronychia
  • Category
    • Preventive Vaccines
    • Therapeutic Vaccines

  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the HIV Vaccines Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the HIV Vaccines Market?
  3. What are the technology trends and regulatory frameworks in the HIV Vaccines Market?
  4. What is the market share of the leading vendors in the HIV Vaccines Market?
  5. Which modes and strategic moves are suitable for entering the HIV Vaccines Market?

Table of Contents
  1. Preface
    1. Objectives of the Study
    2. Market Segmentation & Coverage
    3. Years Considered for the Study
    4. Currency & Pricing
    5. Language
    6. Stakeholders
  2. Research Methodology
    1. Define: Research Objective
    2. Determine: Research Design
    3. Prepare: Research Instrument
    4. Collect: Data Source
    5. Analyze: Data Interpretation
    6. Formulate: Data Verification
    7. Publish: Research Report
    8. Repeat: Report Update
  3. Executive Summary
  4. Market Overview
  5. Market Insights
    1. Market Dynamics
      1. Drivers
        1. Rising investments for HIV vaccine production
        2. Prevalence of HIV worldwide
        3. Increasing awareness due to HIV prevention programs
      2. Restraints
        1. Issues related to HIV drug resistance
      3. Opportunities
        1. Rising affordability of HIV medicines
        2. Increasing R&D activities for HIV vaccines clinical trials
      4. Challenges
        1. Limitations of commercialization of HIV vaccine
    2. Market Segmentation Analysis
    3. Market Trend Analysis
    4. Cumulative Impact of High Inflation
    5. Porter’s Five Forces Analysis
      1. Threat of New Entrants
      2. Threat of Substitutes
      3. Bargaining Power of Customers
      4. Bargaining Power of Suppliers
      5. Industry Rivalry
    6. Value Chain & Critical Path Analysis
    7. Regulatory Framework
  6. HIV Vaccines Market, by Antibodies
    1. Introduction
    2. Dicloxacillin
    3. Fusidic Acid Ointment
    4. Gentamicin Ointment
    5. Mupirocin Ointment
  7. HIV Vaccines Market, by Type
    1. Introduction
    2. Acute Paronychia
    3. Candidal Paronychia
    4. Chronic Paronychia
    5. Pyogenic Paronychia
  8. HIV Vaccines Market, by Category
    1. Introduction
    2. Preventive Vaccines
    3. Therapeutic Vaccines
  9. Americas HIV Vaccines Market
    1. Introduction
    2. Argentina
    3. Brazil
    4. Canada
    5. Mexico
    6. United States
  10. Asia-Pacific HIV Vaccines Market
    1. Introduction
    2. Australia
    3. China
    4. India
    5. Indonesia
    6. Japan
    7. Malaysia
    8. Philippines
    9. Singapore
    10. South Korea
    11. Taiwan
    12. Thailand
    13. Vietnam
  11. Europe, Middle East & Africa HIV Vaccines Market
    1. Introduction
    2. Denmark
    3. Egypt
    4. Finland
    5. France
    6. Germany
    7. Israel
    8. Italy
    9. Netherlands
    10. Nigeria
    11. Norway
    12. Poland
    13. Qatar
    14. Russia
    15. Saudi Arabia
    16. South Africa
    17. Spain
    18. Sweden
    19. Switzerland
    20. Turkey
    21. United Arab Emirates
    22. United Kingdom
  12. Competitive Landscape
    1. Market Share Analysis, 2023
    2. FPNV Positioning Matrix, 2023
    3. Competitive Scenario Analysis
  13. Competitive Portfolio
    1. Key Company Profiles
    2. Key Product Portfolio
  14. List of Figures [Total: 22]
    1. HIV VACCINES MARKET RESEARCH PROCESS
    2. HIV VACCINES MARKET SIZE, 2023 VS 2030
    3. GLOBAL HIV VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
    4. GLOBAL HIV VACCINES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
    5. GLOBAL HIV VACCINES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
    6. HIV VACCINES MARKET DYNAMICS
    7. GLOBAL HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2023 VS 2030 (%)
    8. GLOBAL HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2023 VS 2024 VS 2030 (USD MILLION)
    9. GLOBAL HIV VACCINES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
    10. GLOBAL HIV VACCINES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
    11. GLOBAL HIV VACCINES MARKET SIZE, BY CATEGORY, 2023 VS 2030 (%)
    12. GLOBAL HIV VACCINES MARKET SIZE, BY CATEGORY, 2023 VS 2024 VS 2030 (USD MILLION)
    13. AMERICAS HIV VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    14. AMERICAS HIV VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    15. UNITED STATES HIV VACCINES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
    16. UNITED STATES HIV VACCINES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
    17. ASIA-PACIFIC HIV VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    18. ASIA-PACIFIC HIV VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    19. EUROPE, MIDDLE EAST & AFRICA HIV VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    20. EUROPE, MIDDLE EAST & AFRICA HIV VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    21. HIV VACCINES MARKET SHARE, BY KEY PLAYER, 2023
    22. HIV VACCINES MARKET, FPNV POSITIONING MATRIX, 2023
  15. List of Tables [Total: 288]
    1. HIV VACCINES MARKET SEGMENTATION & COVERAGE
    2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2023
    3. GLOBAL HIV VACCINES MARKET SIZE, 2018-2023 (USD MILLION)
    4. GLOBAL HIV VACCINES MARKET SIZE, 2024-2030 (USD MILLION)
    5. GLOBAL HIV VACCINES MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
    6. GLOBAL HIV VACCINES MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
    7. GLOBAL HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2018-2023 (USD MILLION)
    8. GLOBAL HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2024-2030 (USD MILLION)
    9. GLOBAL HIV VACCINES MARKET SIZE, BY DICLOXACILLIN, BY REGION, 2018-2023 (USD MILLION)
    10. GLOBAL HIV VACCINES MARKET SIZE, BY DICLOXACILLIN, BY REGION, 2024-2030 (USD MILLION)
    11. GLOBAL HIV VACCINES MARKET SIZE, BY FUSIDIC ACID OINTMENT, BY REGION, 2018-2023 (USD MILLION)
    12. GLOBAL HIV VACCINES MARKET SIZE, BY FUSIDIC ACID OINTMENT, BY REGION, 2024-2030 (USD MILLION)
    13. GLOBAL HIV VACCINES MARKET SIZE, BY GENTAMICIN OINTMENT, BY REGION, 2018-2023 (USD MILLION)
    14. GLOBAL HIV VACCINES MARKET SIZE, BY GENTAMICIN OINTMENT, BY REGION, 2024-2030 (USD MILLION)
    15. GLOBAL HIV VACCINES MARKET SIZE, BY MUPIROCIN OINTMENT, BY REGION, 2018-2023 (USD MILLION)
    16. GLOBAL HIV VACCINES MARKET SIZE, BY MUPIROCIN OINTMENT, BY REGION, 2024-2030 (USD MILLION)
    17. GLOBAL HIV VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    18. GLOBAL HIV VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    19. GLOBAL HIV VACCINES MARKET SIZE, BY ACUTE PARONYCHIA, BY REGION, 2018-2023 (USD MILLION)
    20. GLOBAL HIV VACCINES MARKET SIZE, BY ACUTE PARONYCHIA, BY REGION, 2024-2030 (USD MILLION)
    21. GLOBAL HIV VACCINES MARKET SIZE, BY CANDIDAL PARONYCHIA, BY REGION, 2018-2023 (USD MILLION)
    22. GLOBAL HIV VACCINES MARKET SIZE, BY CANDIDAL PARONYCHIA, BY REGION, 2024-2030 (USD MILLION)
    23. GLOBAL HIV VACCINES MARKET SIZE, BY CHRONIC PARONYCHIA, BY REGION, 2018-2023 (USD MILLION)
    24. GLOBAL HIV VACCINES MARKET SIZE, BY CHRONIC PARONYCHIA, BY REGION, 2024-2030 (USD MILLION)
    25. GLOBAL HIV VACCINES MARKET SIZE, BY PYOGENIC PARONYCHIA, BY REGION, 2018-2023 (USD MILLION)
    26. GLOBAL HIV VACCINES MARKET SIZE, BY PYOGENIC PARONYCHIA, BY REGION, 2024-2030 (USD MILLION)
    27. GLOBAL HIV VACCINES MARKET SIZE, BY CATEGORY, 2018-2023 (USD MILLION)
    28. GLOBAL HIV VACCINES MARKET SIZE, BY CATEGORY, 2024-2030 (USD MILLION)
    29. GLOBAL HIV VACCINES MARKET SIZE, BY PREVENTIVE VACCINES, BY REGION, 2018-2023 (USD MILLION)
    30. GLOBAL HIV VACCINES MARKET SIZE, BY PREVENTIVE VACCINES, BY REGION, 2024-2030 (USD MILLION)
    31. GLOBAL HIV VACCINES MARKET SIZE, BY THERAPEUTIC VACCINES, BY REGION, 2018-2023 (USD MILLION)
    32. GLOBAL HIV VACCINES MARKET SIZE, BY THERAPEUTIC VACCINES, BY REGION, 2024-2030 (USD MILLION)
    33. AMERICAS HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2018-2023 (USD MILLION)
    34. AMERICAS HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2024-2030 (USD MILLION)
    35. AMERICAS HIV VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    36. AMERICAS HIV VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    37. AMERICAS HIV VACCINES MARKET SIZE, BY CATEGORY, 2018-2023 (USD MILLION)
    38. AMERICAS HIV VACCINES MARKET SIZE, BY CATEGORY, 2024-2030 (USD MILLION)
    39. AMERICAS HIV VACCINES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
    40. AMERICAS HIV VACCINES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
    41. ARGENTINA HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2018-2023 (USD MILLION)
    42. ARGENTINA HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2024-2030 (USD MILLION)
    43. ARGENTINA HIV VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    44. ARGENTINA HIV VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    45. ARGENTINA HIV VACCINES MARKET SIZE, BY CATEGORY, 2018-2023 (USD MILLION)
    46. ARGENTINA HIV VACCINES MARKET SIZE, BY CATEGORY, 2024-2030 (USD MILLION)
    47. BRAZIL HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2018-2023 (USD MILLION)
    48. BRAZIL HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2024-2030 (USD MILLION)
    49. BRAZIL HIV VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    50. BRAZIL HIV VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    51. BRAZIL HIV VACCINES MARKET SIZE, BY CATEGORY, 2018-2023 (USD MILLION)
    52. BRAZIL HIV VACCINES MARKET SIZE, BY CATEGORY, 2024-2030 (USD MILLION)
    53. CANADA HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2018-2023 (USD MILLION)
    54. CANADA HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2024-2030 (USD MILLION)
    55. CANADA HIV VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    56. CANADA HIV VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    57. CANADA HIV VACCINES MARKET SIZE, BY CATEGORY, 2018-2023 (USD MILLION)
    58. CANADA HIV VACCINES MARKET SIZE, BY CATEGORY, 2024-2030 (USD MILLION)
    59. MEXICO HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2018-2023 (USD MILLION)
    60. MEXICO HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2024-2030 (USD MILLION)
    61. MEXICO HIV VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    62. MEXICO HIV VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    63. MEXICO HIV VACCINES MARKET SIZE, BY CATEGORY, 2018-2023 (USD MILLION)
    64. MEXICO HIV VACCINES MARKET SIZE, BY CATEGORY, 2024-2030 (USD MILLION)
    65. UNITED STATES HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2018-2023 (USD MILLION)
    66. UNITED STATES HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2024-2030 (USD MILLION)
    67. UNITED STATES HIV VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    68. UNITED STATES HIV VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    69. UNITED STATES HIV VACCINES MARKET SIZE, BY CATEGORY, 2018-2023 (USD MILLION)
    70. UNITED STATES HIV VACCINES MARKET SIZE, BY CATEGORY, 2024-2030 (USD MILLION)
    71. UNITED STATES HIV VACCINES MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
    72. UNITED STATES HIV VACCINES MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
    73. ASIA-PACIFIC HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2018-2023 (USD MILLION)
    74. ASIA-PACIFIC HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2024-2030 (USD MILLION)
    75. ASIA-PACIFIC HIV VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    76. ASIA-PACIFIC HIV VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    77. ASIA-PACIFIC HIV VACCINES MARKET SIZE, BY CATEGORY, 2018-2023 (USD MILLION)
    78. ASIA-PACIFIC HIV VACCINES MARKET SIZE, BY CATEGORY, 2024-2030 (USD MILLION)
    79. ASIA-PACIFIC HIV VACCINES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
    80. ASIA-PACIFIC HIV VACCINES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
    81. AUSTRALIA HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2018-2023 (USD MILLION)
    82. AUSTRALIA HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2024-2030 (USD MILLION)
    83. AUSTRALIA HIV VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    84. AUSTRALIA HIV VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    85. AUSTRALIA HIV VACCINES MARKET SIZE, BY CATEGORY, 2018-2023 (USD MILLION)
    86. AUSTRALIA HIV VACCINES MARKET SIZE, BY CATEGORY, 2024-2030 (USD MILLION)
    87. CHINA HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2018-2023 (USD MILLION)
    88. CHINA HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2024-2030 (USD MILLION)
    89. CHINA HIV VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    90. CHINA HIV VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    91. CHINA HIV VACCINES MARKET SIZE, BY CATEGORY, 2018-2023 (USD MILLION)
    92. CHINA HIV VACCINES MARKET SIZE, BY CATEGORY, 2024-2030 (USD MILLION)
    93. INDIA HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2018-2023 (USD MILLION)
    94. INDIA HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2024-2030 (USD MILLION)
    95. INDIA HIV VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    96. INDIA HIV VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    97. INDIA HIV VACCINES MARKET SIZE, BY CATEGORY, 2018-2023 (USD MILLION)
    98. INDIA HIV VACCINES MARKET SIZE, BY CATEGORY, 2024-2030 (USD MILLION)
    99. INDONESIA HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2018-2023 (USD MILLION)
    100. INDONESIA HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2024-2030 (USD MILLION)
    101. INDONESIA HIV VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    102. INDONESIA HIV VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    103. INDONESIA HIV VACCINES MARKET SIZE, BY CATEGORY, 2018-2023 (USD MILLION)
    104. INDONESIA HIV VACCINES MARKET SIZE, BY CATEGORY, 2024-2030 (USD MILLION)
    105. JAPAN HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2018-2023 (USD MILLION)
    106. JAPAN HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2024-2030 (USD MILLION)
    107. JAPAN HIV VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    108. JAPAN HIV VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    109. JAPAN HIV VACCINES MARKET SIZE, BY CATEGORY, 2018-2023 (USD MILLION)
    110. JAPAN HIV VACCINES MARKET SIZE, BY CATEGORY, 2024-2030 (USD MILLION)
    111. MALAYSIA HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2018-2023 (USD MILLION)
    112. MALAYSIA HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2024-2030 (USD MILLION)
    113. MALAYSIA HIV VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    114. MALAYSIA HIV VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    115. MALAYSIA HIV VACCINES MARKET SIZE, BY CATEGORY, 2018-2023 (USD MILLION)
    116. MALAYSIA HIV VACCINES MARKET SIZE, BY CATEGORY, 2024-2030 (USD MILLION)
    117. PHILIPPINES HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2018-2023 (USD MILLION)
    118. PHILIPPINES HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2024-2030 (USD MILLION)
    119. PHILIPPINES HIV VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    120. PHILIPPINES HIV VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    121. PHILIPPINES HIV VACCINES MARKET SIZE, BY CATEGORY, 2018-2023 (USD MILLION)
    122. PHILIPPINES HIV VACCINES MARKET SIZE, BY CATEGORY, 2024-2030 (USD MILLION)
    123. SINGAPORE HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2018-2023 (USD MILLION)
    124. SINGAPORE HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2024-2030 (USD MILLION)
    125. SINGAPORE HIV VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    126. SINGAPORE HIV VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    127. SINGAPORE HIV VACCINES MARKET SIZE, BY CATEGORY, 2018-2023 (USD MILLION)
    128. SINGAPORE HIV VACCINES MARKET SIZE, BY CATEGORY, 2024-2030 (USD MILLION)
    129. SOUTH KOREA HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2018-2023 (USD MILLION)
    130. SOUTH KOREA HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2024-2030 (USD MILLION)
    131. SOUTH KOREA HIV VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    132. SOUTH KOREA HIV VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    133. SOUTH KOREA HIV VACCINES MARKET SIZE, BY CATEGORY, 2018-2023 (USD MILLION)
    134. SOUTH KOREA HIV VACCINES MARKET SIZE, BY CATEGORY, 2024-2030 (USD MILLION)
    135. TAIWAN HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2018-2023 (USD MILLION)
    136. TAIWAN HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2024-2030 (USD MILLION)
    137. TAIWAN HIV VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    138. TAIWAN HIV VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    139. TAIWAN HIV VACCINES MARKET SIZE, BY CATEGORY, 2018-2023 (USD MILLION)
    140. TAIWAN HIV VACCINES MARKET SIZE, BY CATEGORY, 2024-2030 (USD MILLION)
    141. THAILAND HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2018-2023 (USD MILLION)
    142. THAILAND HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2024-2030 (USD MILLION)
    143. THAILAND HIV VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    144. THAILAND HIV VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    145. THAILAND HIV VACCINES MARKET SIZE, BY CATEGORY, 2018-2023 (USD MILLION)
    146. THAILAND HIV VACCINES MARKET SIZE, BY CATEGORY, 2024-2030 (USD MILLION)
    147. VIETNAM HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2018-2023 (USD MILLION)
    148. VIETNAM HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2024-2030 (USD MILLION)
    149. VIETNAM HIV VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    150. VIETNAM HIV VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    151. VIETNAM HIV VACCINES MARKET SIZE, BY CATEGORY, 2018-2023 (USD MILLION)
    152. VIETNAM HIV VACCINES MARKET SIZE, BY CATEGORY, 2024-2030 (USD MILLION)
    153. EUROPE, MIDDLE EAST & AFRICA HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2018-2023 (USD MILLION)
    154. EUROPE, MIDDLE EAST & AFRICA HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2024-2030 (USD MILLION)
    155. EUROPE, MIDDLE EAST & AFRICA HIV VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    156. EUROPE, MIDDLE EAST & AFRICA HIV VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    157. EUROPE, MIDDLE EAST & AFRICA HIV VACCINES MARKET SIZE, BY CATEGORY, 2018-2023 (USD MILLION)
    158. EUROPE, MIDDLE EAST & AFRICA HIV VACCINES MARKET SIZE, BY CATEGORY, 2024-2030 (USD MILLION)
    159. EUROPE, MIDDLE EAST & AFRICA HIV VACCINES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
    160. EUROPE, MIDDLE EAST & AFRICA HIV VACCINES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
    161. DENMARK HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2018-2023 (USD MILLION)
    162. DENMARK HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2024-2030 (USD MILLION)
    163. DENMARK HIV VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    164. DENMARK HIV VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    165. DENMARK HIV VACCINES MARKET SIZE, BY CATEGORY, 2018-2023 (USD MILLION)
    166. DENMARK HIV VACCINES MARKET SIZE, BY CATEGORY, 2024-2030 (USD MILLION)
    167. EGYPT HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2018-2023 (USD MILLION)
    168. EGYPT HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2024-2030 (USD MILLION)
    169. EGYPT HIV VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    170. EGYPT HIV VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    171. EGYPT HIV VACCINES MARKET SIZE, BY CATEGORY, 2018-2023 (USD MILLION)
    172. EGYPT HIV VACCINES MARKET SIZE, BY CATEGORY, 2024-2030 (USD MILLION)
    173. FINLAND HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2018-2023 (USD MILLION)
    174. FINLAND HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2024-2030 (USD MILLION)
    175. FINLAND HIV VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    176. FINLAND HIV VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    177. FINLAND HIV VACCINES MARKET SIZE, BY CATEGORY, 2018-2023 (USD MILLION)
    178. FINLAND HIV VACCINES MARKET SIZE, BY CATEGORY, 2024-2030 (USD MILLION)
    179. FRANCE HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2018-2023 (USD MILLION)
    180. FRANCE HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2024-2030 (USD MILLION)
    181. FRANCE HIV VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    182. FRANCE HIV VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    183. FRANCE HIV VACCINES MARKET SIZE, BY CATEGORY, 2018-2023 (USD MILLION)
    184. FRANCE HIV VACCINES MARKET SIZE, BY CATEGORY, 2024-2030 (USD MILLION)
    185. GERMANY HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2018-2023 (USD MILLION)
    186. GERMANY HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2024-2030 (USD MILLION)
    187. GERMANY HIV VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    188. GERMANY HIV VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    189. GERMANY HIV VACCINES MARKET SIZE, BY CATEGORY, 2018-2023 (USD MILLION)
    190. GERMANY HIV VACCINES MARKET SIZE, BY CATEGORY, 2024-2030 (USD MILLION)
    191. ISRAEL HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2018-2023 (USD MILLION)
    192. ISRAEL HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2024-2030 (USD MILLION)
    193. ISRAEL HIV VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    194. ISRAEL HIV VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    195. ISRAEL HIV VACCINES MARKET SIZE, BY CATEGORY, 2018-2023 (USD MILLION)
    196. ISRAEL HIV VACCINES MARKET SIZE, BY CATEGORY, 2024-2030 (USD MILLION)
    197. ITALY HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2018-2023 (USD MILLION)
    198. ITALY HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2024-2030 (USD MILLION)
    199. ITALY HIV VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    200. ITALY HIV VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    201. ITALY HIV VACCINES MARKET SIZE, BY CATEGORY, 2018-2023 (USD MILLION)
    202. ITALY HIV VACCINES MARKET SIZE, BY CATEGORY, 2024-2030 (USD MILLION)
    203. NETHERLANDS HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2018-2023 (USD MILLION)
    204. NETHERLANDS HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2024-2030 (USD MILLION)
    205. NETHERLANDS HIV VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    206. NETHERLANDS HIV VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    207. NETHERLANDS HIV VACCINES MARKET SIZE, BY CATEGORY, 2018-2023 (USD MILLION)
    208. NETHERLANDS HIV VACCINES MARKET SIZE, BY CATEGORY, 2024-2030 (USD MILLION)
    209. NIGERIA HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2018-2023 (USD MILLION)
    210. NIGERIA HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2024-2030 (USD MILLION)
    211. NIGERIA HIV VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    212. NIGERIA HIV VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    213. NIGERIA HIV VACCINES MARKET SIZE, BY CATEGORY, 2018-2023 (USD MILLION)
    214. NIGERIA HIV VACCINES MARKET SIZE, BY CATEGORY, 2024-2030 (USD MILLION)
    215. NORWAY HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2018-2023 (USD MILLION)
    216. NORWAY HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2024-2030 (USD MILLION)
    217. NORWAY HIV VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    218. NORWAY HIV VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    219. NORWAY HIV VACCINES MARKET SIZE, BY CATEGORY, 2018-2023 (USD MILLION)
    220. NORWAY HIV VACCINES MARKET SIZE, BY CATEGORY, 2024-2030 (USD MILLION)
    221. POLAND HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2018-2023 (USD MILLION)
    222. POLAND HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2024-2030 (USD MILLION)
    223. POLAND HIV VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    224. POLAND HIV VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    225. POLAND HIV VACCINES MARKET SIZE, BY CATEGORY, 2018-2023 (USD MILLION)
    226. POLAND HIV VACCINES MARKET SIZE, BY CATEGORY, 2024-2030 (USD MILLION)
    227. QATAR HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2018-2023 (USD MILLION)
    228. QATAR HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2024-2030 (USD MILLION)
    229. QATAR HIV VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    230. QATAR HIV VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    231. QATAR HIV VACCINES MARKET SIZE, BY CATEGORY, 2018-2023 (USD MILLION)
    232. QATAR HIV VACCINES MARKET SIZE, BY CATEGORY, 2024-2030 (USD MILLION)
    233. RUSSIA HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2018-2023 (USD MILLION)
    234. RUSSIA HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2024-2030 (USD MILLION)
    235. RUSSIA HIV VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    236. RUSSIA HIV VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    237. RUSSIA HIV VACCINES MARKET SIZE, BY CATEGORY, 2018-2023 (USD MILLION)
    238. RUSSIA HIV VACCINES MARKET SIZE, BY CATEGORY, 2024-2030 (USD MILLION)
    239. SAUDI ARABIA HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2018-2023 (USD MILLION)
    240. SAUDI ARABIA HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2024-2030 (USD MILLION)
    241. SAUDI ARABIA HIV VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    242. SAUDI ARABIA HIV VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    243. SAUDI ARABIA HIV VACCINES MARKET SIZE, BY CATEGORY, 2018-2023 (USD MILLION)
    244. SAUDI ARABIA HIV VACCINES MARKET SIZE, BY CATEGORY, 2024-2030 (USD MILLION)
    245. SOUTH AFRICA HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2018-2023 (USD MILLION)
    246. SOUTH AFRICA HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2024-2030 (USD MILLION)
    247. SOUTH AFRICA HIV VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    248. SOUTH AFRICA HIV VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    249. SOUTH AFRICA HIV VACCINES MARKET SIZE, BY CATEGORY, 2018-2023 (USD MILLION)
    250. SOUTH AFRICA HIV VACCINES MARKET SIZE, BY CATEGORY, 2024-2030 (USD MILLION)
    251. SPAIN HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2018-2023 (USD MILLION)
    252. SPAIN HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2024-2030 (USD MILLION)
    253. SPAIN HIV VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    254. SPAIN HIV VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    255. SPAIN HIV VACCINES MARKET SIZE, BY CATEGORY, 2018-2023 (USD MILLION)
    256. SPAIN HIV VACCINES MARKET SIZE, BY CATEGORY, 2024-2030 (USD MILLION)
    257. SWEDEN HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2018-2023 (USD MILLION)
    258. SWEDEN HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2024-2030 (USD MILLION)
    259. SWEDEN HIV VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    260. SWEDEN HIV VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    261. SWEDEN HIV VACCINES MARKET SIZE, BY CATEGORY, 2018-2023 (USD MILLION)
    262. SWEDEN HIV VACCINES MARKET SIZE, BY CATEGORY, 2024-2030 (USD MILLION)
    263. SWITZERLAND HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2018-2023 (USD MILLION)
    264. SWITZERLAND HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2024-2030 (USD MILLION)
    265. SWITZERLAND HIV VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    266. SWITZERLAND HIV VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    267. SWITZERLAND HIV VACCINES MARKET SIZE, BY CATEGORY, 2018-2023 (USD MILLION)
    268. SWITZERLAND HIV VACCINES MARKET SIZE, BY CATEGORY, 2024-2030 (USD MILLION)
    269. TURKEY HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2018-2023 (USD MILLION)
    270. TURKEY HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2024-2030 (USD MILLION)
    271. TURKEY HIV VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    272. TURKEY HIV VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    273. TURKEY HIV VACCINES MARKET SIZE, BY CATEGORY, 2018-2023 (USD MILLION)
    274. TURKEY HIV VACCINES MARKET SIZE, BY CATEGORY, 2024-2030 (USD MILLION)
    275. UNITED ARAB EMIRATES HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2018-2023 (USD MILLION)
    276. UNITED ARAB EMIRATES HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2024-2030 (USD MILLION)
    277. UNITED ARAB EMIRATES HIV VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    278. UNITED ARAB EMIRATES HIV VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    279. UNITED ARAB EMIRATES HIV VACCINES MARKET SIZE, BY CATEGORY, 2018-2023 (USD MILLION)
    280. UNITED ARAB EMIRATES HIV VACCINES MARKET SIZE, BY CATEGORY, 2024-2030 (USD MILLION)
    281. UNITED KINGDOM HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2018-2023 (USD MILLION)
    282. UNITED KINGDOM HIV VACCINES MARKET SIZE, BY ANTIBODIES, 2024-2030 (USD MILLION)
    283. UNITED KINGDOM HIV VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    284. UNITED KINGDOM HIV VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    285. UNITED KINGDOM HIV VACCINES MARKET SIZE, BY CATEGORY, 2018-2023 (USD MILLION)
    286. UNITED KINGDOM HIV VACCINES MARKET SIZE, BY CATEGORY, 2024-2030 (USD MILLION)
    287. HIV VACCINES MARKET SHARE, BY KEY PLAYER, 2023
    288. HIV VACCINES MARKET, FPNV POSITIONING MATRIX, 2023
  16. List of Companies Mentioned [Total: 18]
    1. AlphaVax, Inc.
    2. Antigen Express, Inc.
    3. Argos Therapeutics, Inc.
    4. Bionor Pharmaceuticals
    5. Celldex Therapeutics, Inc.
    6. Crucell N.V.
    7. GeneCure LLC
    8. Genetic Immunity, Inc.
    9. GenVec, Inc.
    10. GeoVax Labs, Inc.
    11. GlaxoSmithKline plc
    12. Immune Response BioPharma, Inc.
    13. Inovio Pharmaceuticals, Inc.
    14. Novartis AG
    15. Oncolys Biopharma
    16. Profectus Biosciences
    17. Sanofi SA
    18. TVAX Biomedical
Frequently Asked Questions
  1. How big is the HIV Vaccines Market?
    Ans. The Global HIV Vaccines Market size was estimated at USD 677.83 million in 2023 and expected to reach USD 943.11 million in 2024.
  2. What is the HIV Vaccines Market growth?
    Ans. The Global HIV Vaccines Market to grow USD 7,011.84 million by 2030, at a CAGR of 39.62%
  3. When do I get the report?
    Ans. Most reports are fulfilled immediately. In some cases, it could take up to 2 business days.
  4. In what format does this report get delivered to me?
    Ans. We will send you an email with login credentials to access the report. You will also be able to download the pdf and excel.
  5. How long has 360iResearch been around?
    Ans. We are approaching our 7th anniversary in 2024!
  6. What if I have a question about your reports?
    Ans. Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available and included in every purchase to help our customers find the research they need-when they need it.
  7. Can I share this report with my team?
    Ans. Absolutely yes, with the purchase of additional user licenses.
  8. Can I use your research in my presentation?
    Ans. Absolutely yes, so long as the 360iResearch cited correctly.
DOWNLOAD A FREE PDF
This free PDF includes market data points, ranging from trend analysis to market estimates & forecasts. See for yourself.